Physician profile
Ted L Freeman
NPI 1881762029
$6,858.33
in general payments reported to CMS, 2019-2025
39 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $853 · 2021: $823 · 2022: $913 · 2023: $884 · 2024: $1,278 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,035.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,880.34 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $1,392.35 | 2019-2025 | Octrode, Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,038.74 | 2020-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $287.68 | 2019-2025 | Ztlido |
| Valinor Pharma, LLC | $284.86 | 2023-2025 | Movantik |
| Daiichi Sankyo INC. | $276.79 | 2019 | |
| Spr Therapeutics, INC | $266.53 | 2021-2025 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $170.85 | 2019-2021 | |
| Depuy Synthes Sales INC. | $162.06 | 2020-2024 | Orthovisc, Monovisc |
| Ipsen Biopharmaceuticals, INC | $157.48 | 2022-2025 | Dysport |
| Pfizer INC. | $82.89 | 2019-2021 | |
| Pacira Therapeutics, INC. | $80.49 | 2019-2021 | |
| Protega Pharmaceutials INC | $79.06 | 2023-2025 | Roxybond |
| Forte Bio-Pharma LLC | $69.45 | 2025 | Prolate, Tanlor, Nalocet |
| Vertos Medical, INC. | $60.88 | 2024 | Mild Device Kit |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.